A detailed history of Howard Hughes Medical Institute transactions in Eli Lilly & CO stock. As of the latest transaction made, Howard Hughes Medical Institute holds 170 shares of LLY stock, worth $142,777. This represents 0.05% of its overall portfolio holdings.

Number of Shares
170
Holding current value
$142,777
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$713.71 - $898.95 $121,330 - $152,821
170 New
170 $132,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $798B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Howard Hughes Medical Institute Portfolio

Follow Howard Hughes Medical Institute and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howard Hughes Medical Institute, based on Form 13F filings with the SEC.

News

Stay updated on Howard Hughes Medical Institute with notifications on news.